Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2021-05-17
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$366.7m
reported value
+9.4% vs Q4 2020
15positions
89.3%in top 10
1 new
11 added
1 reduced
1 sold out
vs Q4 2020
Options: 0 call positions (— notional), 2 put positions ($186.7m notional) – listed below, not included above.
Holdings, Q1 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SPERO THERAPEUTICS INC SPRO | $56.4m15.37% | Reduced -103.0k |
| DICERNA PHARMACEUTICALS INC DRNA | $43.6m11.89% | Added +350.0k |
| BLUEPRINT MEDICINES CORP BPMC | $41.1m11.22% | Added +43.0k |
| NGM BIOPHARMACEUTICALS INC NGM | $32.7m8.91% | Added +118.7k |
| HARPOON THERAPEUTICS INC COM | $32.5m8.87% | New |
| UNIQURE NV QURE | $32.2m8.78% | Added +253.4k |
| MAGENTA THERAPEUTICS INC COM | $29.6m8.08% | Added +235.8k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $27.1m7.38% | Added +42.0k |
| REGENXBIO INC RGNX | $19.1m5.20% | Added +56.0k |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $13.1m3.56% | Added +280.9k |
| AMRYT PHARMA PLC SPONSORED ADS | $11.1m3.04% | Unchanged |
| PIERIS PHARMACEUTICALS INC COM | $9.4m2.58% | Unchanged |
| GALAPAGOS NV LKFT | $9.0m2.45% | Added +46.7k |
| ARGENX SE ARGX | $5.8m1.59% | Added +8.5k |
| GENMAB A/S GMAB | $3.9m1.07% | Added +30.0k |
Sold out since Q4 2020
| Security | Value then |
|---|---|
| ANAPTYSBIO INC ANAB | $26.1m1.2m shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $118.9m300.0k shares | New |
| SPDR SER TR XBI · Put | $67.8m500.0k shares | Unchanged |
Trades reported as a company insider in Q1 2021
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2021-02-08 | SPERO THERAPEUTICS INC 10% owner · See Footnote | Sold | $65.2k3.0k shares |
| 2021-02-04 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Sold | $648.4k34.1k shares |
| 2021-02-03 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Sold | $557.1k29.4k shares |
| 2021-02-02 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Sold | $433.8k22.8k shares |
| 2021-02-01 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Sold | $262.8k13.7k shares |